Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1996 1
1998 1
2000 2
2004 1
2005 2
2007 1
2008 2
2010 5
2011 4
2012 2
2013 4
2014 2
2015 4
2016 5
2017 6
2018 2
2019 1
2020 2
2021 2
2022 4
2023 5
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
Delany-Moretlwe S, Hughes JP, Bock P, Ouma SG, Hunidzarira P, Kalonji D, Kayange N, Makhema J, Mandima P, Mathew C, Spooner E, Mpendo J, Mukwekwerere P, Mgodi N, Ntege PN, Nair G, Nakabiito C, Nuwagaba-Biribonwoha H, Panchia R, Singh N, Siziba B, Farrior J, Rose S, Anderson PL, Eshleman SH, Marzinke MA, Hendrix CW, Beigel-Orme S, Hosek S, Tolley E, Sista N, Adeyeye A, Rooney JF, Rinehart A, Spreen WR, Smith K, Hanscom B, Cohen MS, Hosseinipour MC; HPTN 084 study group. Delany-Moretlwe S, et al. Lancet. 2022 May 7;399(10337):1779-1789. doi: 10.1016/S0140-6736(22)00538-4. Epub 2022 Apr 1. Lancet. 2022. PMID: 35378077 Free PMC article. Clinical Trial.
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
Corey L, Gilbert PB, Juraska M, Montefiori DC, Morris L, Karuna ST, Edupuganti S, Mgodi NM, deCamp AC, Rudnicki E, Huang Y, Gonzales P, Cabello R, Orrell C, Lama JR, Laher F, Lazarus EM, Sanchez J, Frank I, Hinojosa J, Sobieszczyk ME, Marshall KE, Mukwekwerere PG, Makhema J, Baden LR, Mullins JI, Williamson C, Hural J, McElrath MJ, Bentley C, Takuva S, Gomez Lorenzo MM, Burns DN, Espy N, Randhawa AK, Kochar N, Piwowar-Manning E, Donnell DJ, Sista N, Andrew P, Kublin JG, Gray G, Ledgerwood JE, Mascola JR, Cohen MS; HVTN 704/HPTN 085 and HVTN 703/HPTN 081 Study Teams. Corey L, et al. N Engl J Med. 2021 Mar 18;384(11):1003-1014. doi: 10.1056/NEJMoa2031738. N Engl J Med. 2021. PMID: 33730454 Free PMC article. Clinical Trial.
Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults.
Samandari T, Ongalo JB, McCarthy KD, Biegon RK, Madiega PA, Mithika A, Orinda J, Mboya GM, Mwaura P, Anzala O, Onyango C, Oluoch FO, Osoro E, Dutertre CA, Tan N, Hang SK, Hariharaputran S, Lye DC, Herman-Roloff A, Le Bert N, Bertoletti A. Samandari T, et al. J Clin Invest. 2023 Jul 3;133(13):e170011. doi: 10.1172/JCI170011. J Clin Invest. 2023. PMID: 37219944 Free PMC article.
Adapting Longstanding Public Health Collaborations between Government of Kenya and CDC Kenya in Response to the COVID-19 Pandemic, 2020-2021.
Herman-Roloff A, Aman R, Samandari T, Kasera K, Emukule GO, Amoth P, Chen TH, Kisivuli J, Weyenga H, Hunsperger E, Onyango C, Juma B, Munyua P, Wako D, Akelo V, Kimanga D, Ndegwa L, Mohamed AA, Okello P, Kariuki S, De Cock KM, Bulterys M; CDC-Kenya COVID-19 Response Team. Herman-Roloff A, et al. Among authors: samandari t. Emerg Infect Dis. 2022 Dec;28(13):S159-S167. doi: 10.3201/eid2813.211550. Emerg Infect Dis. 2022. PMID: 36502403 Free PMC article. Review.
High Asymptomatic Carriage With the Omicron Variant in South Africa.
Garrett N, Tapley A, Andriesen J, Seocharan I, Fisher LH, Bunts L, Espy N, Wallis CL, Randhawa AK, Miner MD, Ketter N, Yacovone M, Goga A, Huang Y, Hural J, Kotze P, Bekker LG, Gray GE, Corey L; Ubuntu Study Team. Garrett N, et al. Clin Infect Dis. 2022 Aug 24;75(1):e289-e292. doi: 10.1093/cid/ciac237. Clin Infect Dis. 2022. PMID: 35353885 Free PMC article.
The Cooperative Re-Engagement Controlled Trial (CoRECT): Durable Viral Suppression Assessment.
O'Shea J, Fanfair RN, Williams T, Khalil G, Brady KA, DeMaria A Jr, Villanueva M, Randall LM, Jenkins H, Altice FL, Camp N, Lucas C, Buchelli M, Samandari T, Weidle PJ. O'Shea J, et al. Among authors: samandari t. J Acquir Immune Defic Syndr. 2023 Jun 1;93(2):134-142. doi: 10.1097/QAI.0000000000003178. J Acquir Immune Defic Syndr. 2023. PMID: 36812382 Free PMC article. Clinical Trial.
High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.
Jindani A, Harrison TS, Nunn AJ, Phillips PP, Churchyard GJ, Charalambous S, Hatherill M, Geldenhuys H, McIlleron HM, Zvada SP, Mungofa S, Shah NA, Zizhou S, Magweta L, Shepherd J, Nyirenda S, van Dijk JH, Clouting HE, Coleman D, Bateson AL, McHugh TD, Butcher PD, Mitchison DA; RIFAQUIN Trial Team. Jindani A, et al. N Engl J Med. 2014 Oct 23;371(17):1599-608. doi: 10.1056/NEJMoa1314210. N Engl J Med. 2014. PMID: 25337749 Free PMC article. Clinical Trial.
57 results